User Connexion
EN
EN
FR
Company
Our Achievements and Challenges
Our Ambition
Our Commitments
Vetbiobank Team
Technologies
Regenerative Medicine
Neonatal Stem Cells
Publications
F.A.Q
Products
Pipeline
Our Products
Dog's diseases
Cat's diseases
Horse's diseases
Further Developments
Partners
Pharmaceutical Industry Partnerships
Research Partnerships
Training and Knowledge Sharing
Our Supports
News
Press Release
News
Events
Social Networks
FR
EN
Contact
User Connection
Menu
Company
Our Achievements and Challenges
Our Ambition
Our Commitments
Vetbiobank Team
Technologies
Regenerative Medicine
Neonatal Stem Cells
Publications
F.A.Q
Products
Pipeline
Our Products
Dog's diseases
Cat's diseases
Horse's diseases
Further Developments
Partners
Pharmaceutical Industry Partnerships
Research Partnerships
Training and Knowledge Sharing
Our Supports
News
Press Release
News
Events
Social Networks
FR
EN
Contact
User Connection
Contact
Company
Our Achievements and Challenges
Our Ambition
Our Commitments
Vetbiobank Team
Technologies
Regenerative Medicine
Neonatal Stem Cells
Publications
F.A.Q
Products
Pipeline
Our Products
Dog's diseases
Cat's diseases
Horse's diseases
Further Developments
Partners
Pharmaceutical Industry Partnerships
Research Partnerships
Training and Knowledge Sharing
Our Supports
News
Press Release
News
Events
Social Networks
FR
EN
Contact
User Connection
Menu
Company
Our Achievements and Challenges
Our Ambition
Our Commitments
Vetbiobank Team
Technologies
Regenerative Medicine
Neonatal Stem Cells
Publications
F.A.Q
Products
Pipeline
Our Products
Dog's diseases
Cat's diseases
Horse's diseases
Further Developments
Partners
Pharmaceutical Industry Partnerships
Research Partnerships
Training and Knowledge Sharing
Our Supports
News
Press Release
News
Events
Social Networks
FR
EN
Contact
User Connection
Les cellules souches néonatales : un outil incontournable de la pratique vétérinaire
d?avenir
EN SAVOIR PLUS
Des biothérapies de haute technologie
innovantes, au service de la santé animale
EN SAVOIR PLUS
Apporter le meilleur de la médecine
régénérative au plus grand nombre
EN SAVOIR PLUS
Des biothérapies développées et fabriquées
en France dans le respect des bonnes
pratiques
EN SAVOIR PLUS
A unique know-how in cell therapy
EN SAVOIR PLUS
Des technologies développées dans le
respect de l?éthique et du bien-être animal
EN SAVOIR PLUS
Précédent
Suivant
1er Etablissement Pharmaceutique Franc?ais de me?decine re?ge?ne?rative ve?te?rinaire
Retour
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Menu
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Biotech Finances
Plusieurs start-ups françaises développent des thérapies prometteuses pour l'arthrose aussi bien pour la santé humaine que vétérinaire.
- June 2024